Development and validation of a claims-based measure as an indicator for disease severity in patients with multiple sclerosis treated with disease-modifying drugs
Authors: Michael Munsell, Molly Frean, Joseph Menzin, and Amy L. Phillips
Published: BMC Neurology
Click here for the article.